Skip to main content
GH

GluCare.Health

GluCare.Health provides a hybrid care model for diabetes and endocrine disorders, integrating continuous remote data monitoring with a multidisciplinary clinical team. The platform uses AI-powered diagnostics and digital therapeutics to deliver personalized, data-driven treatment plans and proactive patient engagement for improved metabolic health.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Managing diabetes and complex endocrine disorders often involves fragmented care, relying on infrequent in-person visits and generic treatment plans. This approach can lead to suboptimal patient outcomes and a lack of continuous support for individuals managing chronic conditions.

Solution

GluCare.Health offers a hybrid care model that integrates continuous remote data monitoring (RCDM) with a multidisciplinary clinical team for comprehensive diabetes and endocrinology management. The platform leverages wearable technology and AI-powered diagnostics to provide hyper-personalized, data-driven care plans. This model emphasizes patient engagement through frequent virtual touchpoints, enabling proactive behavioral change and improved metabolic health outcomes. By combining digital therapeutics with in-clinic workflows, GluCare aims to deliver superior, evidence-based care for a range of metabolic and endocrine conditions.

Target Audience

The primary target audience includes individuals with diabetes, pre-diabetes, and other endocrine or metabolic disorders seeking continuous, personalized, and data-driven healthcare solutions.

Features

  • Remote Continuous Data Monitoring (RCDM) utilizing wearables and Continuous Glucose Monitors (CGMs).
  • AI-powered diagnostic tools for in-clinic assessments, including liver scans and retinal imaging.
  • A multidisciplinary care team comprising endocrinologists, dietitians, lifestyle coaches, and general practitioners.
  • Digital Therapeutics (DTx) integrated into personalized treatment plans.
  • Data analytics platform that processes patient data for real-time insights and trend analysis.
  • Patient engagement through a dedicated app and frequent virtual consultations.
  • Clinical research and publication of outcomes data, adhering to ICHOM standards.
  • Specialized care pathways for Type 1 Diabetes, Type 2 Diabetes, Pre-diabetes, PCOS, and various endocrine disorders.
  • Partnership with Oura for enhanced sleep and activity tracking.
This profile is AI-generated and may contain inaccuracies.